IBB vs. SCHD
IBB (iShares Nasdaq Biotechnology ETF) and SCHD (Schwab U.S. Dividend Equity ETF) are both exchange-traded funds - IBB is a Health & Biotech Equities fund tracking the NASDAQ Biotechnology Index, while SCHD is a Dividend fund tracking the Dow Jones U.S. Dividend 100 Index. Both are passively managed. Over the past 10 years, IBB returned 6.75%/yr vs 12.65%/yr for SCHD. A 0.54 correlation means they provide meaningful diversification when combined. IBB charges 0.47%/yr vs 0.06%/yr for SCHD.
Performance
IBB vs. SCHD - Performance Comparison
Loading charts...
Returns By Period
In the year-to-date period, IBB achieves a -1.02% return, which is significantly lower than SCHD's 18.71% return. Over the past 10 years, IBB has underperformed SCHD with an annualized return of 6.75%, while SCHD has yielded a comparatively higher 12.65% annualized return.
IBB
- 1D
- -0.90%
- 1M
- -1.78%
- YTD
- -1.02%
- 6M
- -1.60%
- 1Y
- 31.79%
- 3Y*
- 9.31%
- 5Y*
- 1.05%
- 10Y*
- 6.75%
SCHD
- 1D
- -0.03%
- 1M
- 2.12%
- YTD
- 18.71%
- 6M
- 19.28%
- 1Y
- 26.37%
- 3Y*
- 14.73%
- 5Y*
- 8.49%
- 10Y*
- 12.65%
IBB vs. SCHD - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|---|---|---|---|---|
IBB iShares Nasdaq Biotechnology ETF | -1.02% | 27.98% | -2.41% | 3.76% | -13.69% | 0.95% | 26.01% | 25.42% | -9.53% | 21.08% |
SCHD Schwab U.S. Dividend Equity ETF | 18.71% | 4.34% | 11.66% | 4.54% | -3.26% | 29.87% | 15.03% | 27.29% | -5.56% | 20.85% |
Correlation
The correlation between IBB and SCHD is 0.45, which is low. Their price movements are largely independent, making them effective diversification partners.
| Correlation | |
|---|---|
Correlation (1Y) Calculated over the trailing 1-year period | 0.45 |
Correlation (3Y) Calculated over the trailing 3-year period | 0.57 |
Correlation (5Y) Calculated over the trailing 5-year period | 0.57 |
Correlation (10Y) Calculated over the trailing 10-year period | 0.52 |
Correlation (All Time) Calculated using the full available price history since Oct 21, 2011 | 0.54 |
The correlation between IBB and SCHD shifts across timeframes, from 0.45 (1 year) to 0.57 (3 years), reflecting how their relationship changes across market environments.
IBB vs. SCHD - Sectors Allocation Comparison
Sectors
IBB
SCHD
Healthcare
Basic Materials
-
Communication Services
-
Consumer Cyclical
-
Consumer Defensive
-
Energy
-
Financial Services
-
Industrials
-
Real Estate
-
-
Technology
-
Utilities
-
Healthcare
IBB
SCHD
Basic Materials
IBB
-
SCHD
Communication Services
IBB
-
SCHD
Consumer Cyclical
IBB
-
SCHD
Consumer Defensive
IBB
-
SCHD
Energy
IBB
-
SCHD
Financial Services
IBB
-
SCHD
Industrials
IBB
-
SCHD
Real Estate
IBB
-
SCHD
-
Technology
IBB
-
SCHD
Utilities
IBB
-
SCHD
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
IBB vs. SCHD — Risk / Return Rank
IBB
SCHD
IBB vs. SCHD - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for iShares Nasdaq Biotechnology ETF (IBB) and Schwab U.S. Dividend Equity ETF (SCHD). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
| IBB | SCHD | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | -0.83 | ||
| Sortino ratioReturn per unit of downside risk | -1.43 | ||
| Omega ratioGain probability vs. loss probability | 1.27 | 1.43 | -0.16 |
| Calmar ratioReturn relative to maximum drawdown | 3.32 | 5.74 | -2.43 |
| Martin ratioReturn relative to average drawdown | 10.36 | 14.06 | -3.70 |
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month. | |||
Loading charts...
Sharpe Ratios by Period
| IBB | SCHD | Difference | |
|---|---|---|---|
Sharpe Ratio (1Y)Calculated over the trailing 1-year period | 1.59 | 2.43 | -0.83 |
Sharpe Ratio (5Y)Calculated over the trailing 5-year period | 0.05 | 0.59 | -0.55 |
Sharpe Ratio (10Y)Calculated over the trailing 10-year period | 0.29 | 0.76 | -0.47 |
Sharpe Ratio (All Time)Calculated using the full available price history | 0.26 | 0.86 | -0.60 |
Drawdowns
IBB vs. SCHD - Drawdown Comparison
The maximum IBB drawdown since its inception was -62.85%, which is greater than SCHD's maximum drawdown of -33.37%. Use the drawdown chart below to compare losses from any high point for IBB and SCHD.
Loading charts...
Drawdown Indicators
| IBB | SCHD | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -62.85% | -33.37% | -29.48% |
Max Drawdown (1Y)Largest decline over 1 year | -9.63% | -4.61% | -5.02% |
Max Drawdown (3Y)Largest decline over 3 years | -24.85% | -16.13% | -8.72% |
Max Drawdown (5Y)Largest decline over 5 years | -39.82% | -16.85% | -22.97% |
Max Drawdown (10Y)Largest decline over 10 years | -39.82% | -33.37% | -6.45% |
Current DrawdownCurrent decline from peak | -5.97% | -1.64% | -4.33% |
Average DrawdownAverage peak-to-trough decline | -21.17% | -3.32% | -17.85% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 3.08% | 1.88% | +1.20% |
Volatility
IBB vs. SCHD - Volatility Comparison
iShares Nasdaq Biotechnology ETF (IBB) has a higher volatility of 6.87% compared to Schwab U.S. Dividend Equity ETF (SCHD) at 2.83%. This indicates that IBB's price experiences larger fluctuations and is considered to be riskier than SCHD based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| IBB | SCHD | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 6.87% | 2.83% | +4.04% |
Volatility (6M)Calculated over the trailing 6-month period | 15.57% | 7.60% | +7.97% |
Volatility (1Y)Calculated over the trailing 1-year period | 20.10% | 10.94% | +9.16% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 21.97% | 14.38% | +7.59% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 23.22% | 16.72% | +6.50% |
IBB vs. SCHD - Expense Ratio Comparison
IBB has a 0.47% expense ratio, which is higher than SCHD's 0.06% expense ratio.
Dividends
IBB vs. SCHD - Dividend Comparison
IBB's dividend yield for the trailing twelve months is around 0.23%, less than SCHD's 3.27% yield.
| Position | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
IBB iShares Nasdaq Biotechnology ETF | 0.23% | 0.23% | 0.29% | 0.26% | 0.31% | 0.21% | 0.21% | 0.33% | 0.20% | 0.30% | 0.19% | 0.03% |
SCHD Schwab U.S. Dividend Equity ETF | 3.27% | 3.82% | 3.64% | 3.49% | 3.39% | 2.78% | 3.16% | 2.98% | 3.06% | 2.63% | 2.89% | 2.97% |
Frequently Asked Questions
IBB and SCHD have a correlation of 0.45, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
IBB has higher volatility (6.87%) compared to SCHD (2.83%). In terms of maximum drawdown, IBB dropped -62.85% vs SCHD's -33.37%.
On 10-year performance, SCHD leads with 12.65% vs 6.75% for IBB. On fees, SCHD is cheaper at 0.06% per year. On volatility, SCHD has been the lower-risk option at 2.83%. The better choice depends on whether you care most about return, fees, risk, or income.
Over the 10-year period, SCHD has performed better with a 12.65% return vs 6.75%. Past performance does not guarantee future results, so compare this with risk, fees, and fund exposure.
SCHD is cheaper with a 0.06% expense ratio, compared with 0.47% for IBB.
SCHD has the higher dividend yield at 3.27%, compared with 0.23% for IBB.
IBB is categorized as Health & Biotech Equities, while SCHD is Dividend. IBB tracks NASDAQ Biotechnology Index, while SCHD tracks Dow Jones U.S. Dividend 100 Index. They also come from different issuers: iShares and Charles Schwab. Their fees differ too: 0.47% for IBB and 0.06% for SCHD.
SCHD currently has the higher Sharpe Ratio (2.43 vs 1.59), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.
Find the right allocation for IBB and SCHD
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer